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Abstract: Scaffolds constitute an important element in vascularized tissues and are therefore
investigated for providing the desired mechanical stability and enabling vasculogenesis
and angiogenesis. In this study, supplementation of hydrogels containing either MatrigelTM and rat
tail collagen I (MatrigelTM/rCOL) or human collagen (hCOL) with SeaPlaqueTM agarose were analyzed
with regard to construct thickness and formation and characteristics of endothelial cell (EC) networks
compared to constructs without agarose. Additionally, the effect of increased rCOL content in
MatrigelTM/rCOL constructs was studied. An increase of rCOL content from 1 mg/mL to 3 mg/mL
resulted in an increase of construct thickness by approximately 160%. The high rCOL content,
however, impaired the formation of an EC network. The supplementation of MatrigelTM/rCOL with
agarose increased the thickness of the hydrogel construct by approximately 100% while supporting
the formation of a stable EC network. The use of hCOL/agarose composite hydrogels led to a slight
increase in the thickness of the 3D hydrogel construct and supported the formation of a multi-layered
EC network compared to control constructs. Our findings suggest that agarose/collagen-based
composite hydrogels are promising candidates for tissue engineering of vascularized constructs as
cell viability is maintained and the formation of a stable and multi-layered EC network is supported.
Keywords: collagen hydrogel; hybrid hydrogel; tissue engineering; endothelial cell network
1. Introduction
Tissue engineering aims to develop in vitro tissues to improve or replace impaired biological
tissues in vivo. To date, clinical applications of tissue engineering are limited to tissues which do
not require vascularization nor anastomosis [1–4]. The 3D engineered tissues exceeding 200 µm
(the effective diffusion limit of oxygen), which are densely populated with cells, quickly develop a
necrotic core, if they are not vascularized [5]. Therefore, the vascularization of the engineered tissue is
a major challenge in tissue engineering.
In the last decade, research advanced in pre-vascularization strategies with the aim to create
vascular networks resembling the physiological capillary bed. The vascular network should be
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introduced into engineered tissues prior to implantation to allow microsurgical anastomosis to
the host vasculature, followed by immediate perfusion of the engineered construct with blood.
In general, vascularization strategies can be classified into three categories: Decellularization
and re-endothelialization of vascularized tissues, micro-fabrication, and self-assembly.
In the case of decellularization, a preservation of organ/tissue vasculature is achieved through
decellularization procedures by which cellular material is removed while maintaining the naturally
existing 3D vasculature as well as the ECM structure. The maintained vascular tree is subsequently
repopulated and re-endothelialized with human cells generating a perfusable construct while preventing
thrombosis [6,7]. A major hurdle associated with the use of decellularized matrices of xenogeneic
origin for vascularized tissue and transplantation in general, is the need of the complete removal of
residual antigenic substances before widespread clinical application [8].
The micro-fabrication approach uses different technologies in an attempt to generate channel
structures to guide endothelialization within 3D scaffolds [9]. Such structures are, however, still far
from replicating the complex architecture and functionality of the capillary bed, making their immediate
clinical translation challenging. Additionally, most micro-fabricated systems do not provide sites for
direct anastomosis with the host vasculature and mainly rely on the rather slow process of ingrowth
and subsequent connection to the host vasculature after subcutaneous transplantation, as a proof of
concept for graft perfusion upon implantation [10–12].
The self-assembly strategy originates from the ability of ECs to inherently form vascular structures
through a spontaneous assembly under pro-vasculogenic culture settings. This ability has been
widely explored in both, in vitro and in vivo studies, with the goal to incorporate such vascular-like
networks in engineered tissues. The self-assembly strategy for human vascularized tissues relies at
least on three key elements: ECs forming a capillary-like vascular network, supporting cells stabilizing
the capillary-like vascular network, and scaffolds allowing cell interactions and thus vascular-like
network formation [13].
Scaffolds constitute an important element in vascularized tissues using self-assembly strategies.
Different scaffolds have been investigated to provide the desired mechanical stability in 3D and to
allow a vasculogenic and angiogenic remodeling [14]. For instance, in the context of bone tissue
engineering, an attempt of generating vascularized bone construct was reported by Ying et al. where
human blood-derived endothelial colony-forming cells (ECFCs) were encapsulated with bone marrow
derived mesenchymal stem cells (MSCs) in a methacrylated gelatin hydrogel (GelMA) [15]. The MSCs
induced the self-assembly of ECFCs into tubular structures with a lumen [15]. Additionally, the study
demonstrated that MSCs provided coverage of the capillary like structures, expressing α-smooth
muscle actin (α-SMA) and presenting pericyte-like phenotype [15]. In terms of scaffold’s mechanical
properties, the self-assembly into vascular-like structures was highly dependent on the crosslinking
extent and the stiffness of the GelMA, which could be easily tuned by polymerization with UV light,
or the degree of methacrylation of the polymer [15]. For soft tissues, an engineered muscle flap
for reconstruction of large soft tissue defects was reported by Shandalov et al. [16]. For that, a 3D
biodegradable poly-l-lactic acid (PLLA)/poly(lactic-coglycolic acid) (PLGA) was used as scaffold to
generate muscle tissue in vitro by a co-culture of myoblasts, fibroblasts, and endothelial cells [16].
The construct was cultured in vitro for 10 days until formation of small capillary net [16]. The tissue
construct was then implanted in mice with the capillaries sprouted from the recipient’s femoral
artery and vein [16]. The graft was finally transferred as a flap to fill a full-thickness abdominal wall
defect [16]. The transferred flap showed full integration in the surrounding tissue and proved viable
and well-vascularized while providing mechanical support to the abdominal wall [16]. Both natural
and synthetic scaffolds are used for the formation of EC vascular-like network. Natural scaffolds
comprise biopolymers such as collagens, fibrin, and gelatin matrices [17,18], while commonly used
synthetic scaffolds include poly-l-lactic acid (PLLA) and poly-lactic-co-glycolic acid (PLGA) [19].
Previously, our group has used natural scaffolds either as an animal-derived composite of
MatrigelTM/rCOL or xeno-free hCOL only [20,21]. The combination of human umbilical vein endothelial
Gels 2020, 6, 27 3 of 16
cells (HUVECs) and human adipose tissue-derived stromal cells (hASCs) in a hydrogel construct
containing hCOL cultured in serum-free medium supported the formation of stable EC network;
however, it led to thinner and a single-layered EC network compared to a multi-layered network
in MatrigelTM/rCOL [21]. Here, we investigate the use of agarose in combination with collagen as
composite hydrogel scaffolds to support the formation of 3D EC networks.
Agarose is a polysaccharide of 3,6-anhydrous-L-galactose and D-galactose repeating units [22].
Upon gelation, agarose forms a rigid and porous network and it is often investigated in the context
of therapies for central nervous system injury and disease, where it supports neurite extension [23].
Agarose can form interpenetrating networks with some natural hydrogels, such as collagen, chitosan,
and gelatin [24–26]. It also allows biomolecules such as RGD to be covalently linked to agarose’s
polysaccharide chains. In addition, biomolecules can be also physically entrapped in the agarose.
Immobilizing biomolecules in agarose hydrogel improves its bio-compatibility and bio-activity [27].
In the context of vascularized tissue engineering, collagen-agarose composite hydrogels offer
the possibility to 3D print collagen material, which is otherwise difficult to achieve using native
collagen only [28].
In this study, SeaPlaqueTM agarose was used. It is a low temperature melting agarose with a
gelling temperature between 20 ◦C and 30 ◦C. The effect of hydrogel composition on the thickness of
the construct and the EC network structure was investigated.
2. Results and Discussion
2.1. High Concentration of rCOL Increases Construct Thickness but Does Not Support the Formation of
an EC Network
A modification of the gel composition could lead to an increase in construct thickness by tuning
the gel stiffness and consequently reducing gel shrinkage. This can be achieved by increasing the protein
concentration while leaving the cell density unchanged. To test this hypothesis, the concentration of
rCOL was increased from the standard content of 1 mg/mL to 3 mg/mL while maintaining the MatrigelTM
concentration (0.9 mg/mL) in MatrigelTM/rCOL constructs.
After 2 days of culture, first signs of green fluorescent protein labeled-HUVEC (GFP-HUVEC)
self-assembly were observed in the standard gel containing 1 mg/mL rCOL (Figure 1a). In contrary,
GFP-HUVECs exhibited a round morphology in 3 mg/mL rCOL (Figure 1b). After 9 days of culture,
a formation of a stable HUVEC network was observed in control construct (Figure 1c), while a low
GFP-HUVECs cell number was observed in 3 mg/mL rCOL hydrogels developing a more elongated
morphology compared to day 2 and forming only short vascular-like structures (Figure 1d).
This increase in rCOL concentration resulted in a drastic increase of construct thickness in
the 3 mg/mL rCOL constructs (~200 µm) compared to the control containing 1 mg/mL rCOL (~60 µm),
as assessed through analysis of DAPI staining of cross-sections after 2 weeks in culture (Figure 1e,f).
However, the 3 mg/mL rCOL containing hydrogel did not support the spontaneous formation of an
EC network. This is probably due to the increase of scaffold’s stiffness as previously suggested by
Rao et al. [29]. In their study, Rao and colleagues investigated the degree of vascular-like network
formation by HUVECs when co-cultured with MSCs in 3D collagen/fibrin gel [29]. An increase
of collagen I content resulted in cell death and thus a decreased HUVEC network formation [29].
Measuring the mechanical properties of the matrices showed that the latter increased with increasing
collagen I content. This indicates that increasing mechanical stiffness of the matrix correlates inversely
with EC vascular-network formation [29]. Ideally, the self-assembled vascular-like network generated
in our study is intended to be used for the pre-vascularization of various engineered tissues including
those exhibiting high mechanical properties. In a such case, the use of composite matrices was reported
to successfully support the formation of EC vascular-like networks. For instance, the addition of
nanoparticulate hydroxyapatite, bone-like mineral, to collagen I/fibrin matrices was shown to reduce
the matrix compaction while maintaining high mechanical properties. The formation of a HUVEC
vascular-like network was observed in co-culture with human bone marrow-derived MSCs in such a
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material [30]. In a different study, attempts were made to improve the mechanical stability of scaffolds
for vascularization by self-assembly by using a photopolymerizable gelatin methacrylate (GelMA)
hydrogel [15]. ECFCs and MSCs in the GelMA hydrogels generated extensive capillary-like networks
in vitro [15]. The capillary-like network established a functional anastomosis with host vasculature,
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addition  of  nanoparticulate  hydroxyapatite,  bone‐like mineral,  to  collagen  I/fibrin matrices was 
shown  to  reduce  the  matrix  compaction  while  maintaining  high  mechanical  properties.  The 
formation of a HUVEC vascular‐like network was observed in co‐culture with human bone marrow‐
Figure 1. Assessment of GFP-HUVEC self-assembly into a network when co-cultured with unlabeled
hASCs in 3D hydrogels of different rCOL concentrations. (a,c) Top view of 3D construct showing
GFP- HUVEC in a hydrogel containing MatrigelTM and 1 mg/mL rCOL after 2 and 9 days in culture,
respectively. (b,d) Top view of 3D construct showing GFP-labeled human umbilical vein endothelial
cells (HUVEC) in a hydrogel containing MatrigelTM and 3 mg/mL rCOL after 2 and 9 days in culture,
respectively. (e,f) 4’,6-diamidino-2-phenylindole (DAPI) staining of cross sections of GFP-HUVEC/hASC
constructs containing MatrigelTM and 1 mg/mL or 3 mg/mL rCOL, respectively. White double arrows
depict the height of the 3D hydrogel construct, the dashed lines depict the border between SIS and 3D
hydr gel construct, and white triangles exemplary depict GFP-HUVECs. Scale bar: (a–d): 500 µm,
(e,f): 200 µm.
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In our study, the increase of rCOL in MatrigelTM/rCOL did not elicit the desired response.
Therefore, another approach was followed by supplementing the original construct composition
with agarose.
2.2. Agarose-Supplementation Supports 3D EC Network Formation in MatrigelTM/rCOL and hCOL
SeaPlaqueTM agarose was added to the hydrogel containing cells and MatrigelTM/rCOL or hCOL
at a final concentration of 0.03%. At day 2 of culture, no difference in cell density was observed between
the control constructs containing hCOL or MatrigelTM/rCOL (Figure 2a,c) and constructs supplemented
with agarose (Figure 2b,d). Under prolonged culture for 14 days, the GFP-HUVECs self-assembled
into a vascular-like network in both control constructs (Figure 2e,g) and those supplemented with
agarose (Figure 2f,h). In addition, from visual inspection of the 2D fluorescence images, the networks
formed in agarose-containing constructs seemed to be denser (Figure 2f,h) than those formed in
controls (Figure 2e,g). Additionally, unlike a high concentration of rCOL, the use of SeaPlaqueTM
agarose did not cause tremendous cell loss. This finding is in line with a study, where Kreimendahl
and colleagues used a 3D printable agarose-type I collagen blend and enhanced the formation of
capillary-like structures by HUVECs when co-cultured with human dermal fibroblasts for 14 days
in DMEM [28]. The study has assessed the formation of HUVEC capillary-like structures upon
modification of agarose content and showed that a content of 0.5% resulted in a minimal cell loss while
enabling the formation of HUVEC networks. A higher agarose content led to cell loss and therefore
failed to support the formation of HUVEC networks. This might be attributed to the agarose-induced
disruption of collagen remodeling by cells as demonstrated in a separate study [31]. Ulrich et al.
showed that agarose strongly impairs cell-directed assembly of large collagen bundles by structurally
coupling and reinforcing the collagen fibers which results in steric barriers to cell motility [26,31].
In our study, a concentration of 0.03% agarose was investigated as a proof of concept; higher agarose
concentrations could be tested for future analysis to investigate the extent to which EC networks can
form at higher agarose concentrations.
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Figure 2. HUVECs self-assemble into an EC network e co-cultured with unlabeled-hASC in 3D
hydrogel containing 0.03% SeaPlaqueTM agarose. 3D hydrogel constructs containing GFP-HUVECs
after 2 (a–d) and 14 days (e–h) of culture using hCOL (a,e), hCOL/Agarose (b,f), MatrigelTM/rCOL (c,g),
MatrigelTM/rCOL/Agarose (d,h). EC network formation started at day 2 of cultivation in all hydrogel
settings. The formed networks were stable during the cultivation period of 14 days. Scale bar: 200 µm.
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2.3. The Supplementation of MatrigelTM/rCOL Construct with SeaPlaqueTM Agarose Leads to Thicker
Hydrogel Constructs
The construct thickness was measured based on imaging of three cryosections for one analyzed
construct per setting. Images of the whole cryosection were taken (Figure 3a–d) and five random
thickness measurements were taken per image (roughly 8–9 images per cryosection). The mean
thickness was calculated from 128-132 measurements per hydrogel setting.





construct per setting.  Images of  the whole cryosection were  taken  (Figure 3a–d) and  five random 
thickness measurements were  taken  per  image  (roughly  8–9  images  per  cryosection). The mean 
thickness was calculated from 128‐132 measurements per hydrogel setting. 
The  average  thickness  of hCOL‐constructs  (90  μm)  is  slightly  lower  than  in  hCOL/Agarose 
construct  (100  μm)  showing  that  agarose  supplementation  did  not  change  the  thickness  of  the 
hydrogel  in  hCOL‐based  constructs  (Figure  3a,b,e).  Interestingly,  the  addition  of  agarose  to  the 
hydrogel containing MatrigelTM/rCOL contributed to a drastic increase in construct thickness of 100% 
from  60  μm  in  control  constructs  (Figure  3c,e)  to  approximately  118  μm  in  agarose  containing 
constructs (Figure 3d,e). The thickness of agarose‐free constructs in MatrigelTM/rCOL and hCOL is 
different even  though both  constructs contain  the  same  total protein  content. However, different 
protein compositions with hCOL made of over 97% Collagen I, while MatrigelTM/rCOL is composed 
of rat collagen type I and a mixture of basement membrane proteins (MatrigelTM)—mainly laminin, 
collagen  IV, entactin  [32]—results  in a higher collagen  I content  in hCOL constructs compared  to 
MatrigelTM/rCOL  hydrogels.  It  is  reported  that  endothelial  cells mediate  collagen  I  contractions, 
which are  inversely  related  to collagen concentration  [33]. Additionally,  the hCOL and  rCOL are 





microstructure,  and  final  mechanical  properties  of  formed  matrices  [34,35].  This  may  lead  to 
variations in remodeling of the hydrogel by cells and its contraction resulting in different hydrogel 











for  each  hydrogel  setting with  90  μm  for  hCOL  (a),  100  μm  for  hCOL/Agarose  (b),  60  μm  for 
MatrigelTM/rCOL  (c), and 118  μm  for MatrigelTM/rCOL/Agarose  (d).  (e) A  calculation of  construct 
Figure 3. Construct thickness increased slightly in agarose supplemented hCOL and considerably
in MatrigelTM/rCOL constructs. (a–d) Images of cryo-sections from 3D hydrogel constructs in hCOL
(a), hCOL/Agarose (b), MatrigelTM/rCOL (c), MatrigelTM/rCOL/Agarose (d). The white dashed lines
define the limits of the hydrogel and SIS construct while the red solid line indicates the hydrogel/SIS
border. The hydrogel construct is located on the upper side of the red line and contains HUVECs
and hASCs visualized with DAPI staining (a–d). The up down arrows indicate the average construct
thickness for each hydrogel setting with 90 µm for hCOL (a), 100 µm for hCOL/Agarose (b), 60 µm
for MatrigelTM/rCOL (c), and 118 µm for MatrigelTM/rCOL/Agarose (d). (e) A calculation of construct
thickness was done by imaging of three different cryosections for each hydrogel setting (one construct
analyzed per setting). The cross-section of the whole construct was imaged (approximately 9 images
per cryosection) and five random thickness measurements were taken per image. Hydrogel thickness
is presented as mean ± standard deviation (SD). Scale bar: 200 µm.
The average thickness of hCOL-constructs (90 µm) is slightly lower than in hCOL/Agarose
construct (100 µm) showing that agarose supplementation did not change the thickness of the hydrogel
in hCOL-based constructs (Figure 3a,b,e). Interestingly, the addition of agarose to the hydrogel
containing MatrigelTM/rCOL contributed to a drastic increase in construct thickness of 100% from
60 µm in control constructs (Figure 3c,e) to approximately 118 µm in agarose containing constructs
(Figure 3d,e). The thickness of agarose-free constructs in MatrigelTM/rCOL and hCOL is different even
though both constructs contain the same total protein content. However, different protein compositions
with hCOL made of over 97% Collagen I, while MatrigelTM/rCOL is composed of rat collagen
type I and a mixture of basement membrane proteins (MatrigelTM)—mainly laminin, collagen IV,
entactin [32]—results in a higher collagen I content in hCOL constructs compared to MatrigelTM/rCOL
hydrogels. It is reported that endothelial cells mediate collagen I contractions, which are inversely
related to collagen concentration [33]. Additionally, the hCOL and rCOL are derived differently from
different sources. hCOL is derived from extracellular matrix secreted by human fibroblasts while
rCOL is produced by the digestion of rat tail tissue. The different extraction methods of collagen
may lead to different collagen fibers properties (e.g., size, length, and molecular weight) and thus
collagen monomers and/or oligomers with different properties. Additionally, it was demonstrated
that type I collagen oligomers affect in-vitro polymerization in terms of kinetics, fibril microstructure,
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and final mechanical properties of formed matrices [34,35]. This may lead to variations in remodeling
of the hydrogel by cells and its contraction resulting in different hydrogel thicknesses [36]. This can
explain the lower construct thickness in MatrigelTM/rCOL compared to hCOL. As for the increase of
thickness in agarose containing constructs, this can be attributed to an increase of hydrogel density by
solidified agarose, which is a very slow degrading material and is indigestible for mammalian cells.
2.4. Supplementation of hCOL Construct with SeaPlaqueTM Agarose Leads to Thinner Cords but a
Multi-Layered EC Network
The quantification of the network parameters in constructs containing either hCOL/Agarose or
MatrigelTM/rCOL/Agarose was performed on the basis of 3D reconstruction of the network using
z-stacks of the EC network obtained by multiphoton microscopy which were processed using Imaris
software (Figure 4, Table 1).
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MatrigelTM/rCOL/Agarose  (d,h)  cultivated  for  14  days.  (a–d)  3D  reconstruction  of  EC  network 
employing  the  calculated mean  diameter  for  each  hydrogel  setting.  (e–h)  Side  view  of  the  3D 
reconstruction  demonstrating  the  height  of  the  EC  network.  Networks  generated  in  agarose 
supplemented  hCOL  hydrogel  are multi‐layered with  larger  height  and  exhibit  a  smaller mean 
diameter  compared  to  constructs  generated with hCOL which have  a mono‐layer  structure with 





4b)  compared  to  network  formed  in  agarose‐free  hCOL  construct  (Figure  4a). Additionally,  the 
network in hCOL seemed to resemble a monolayer and has a smaller height (Figure 4e) compared to 
a multi‐layered network in hCOL‐Agarose construct (Figure 4f). These differences are confirmed by 
quantification  of  network  parameters  in  constructs  containing  hCOL/Agarose.  The  latter  has  a 
smaller network mean diameter (7.7  2.6 μm, Table 1) compared to agarose‐free hCOL as shown in 
a  previous  study  by  our  group  (12.2  ±  3.3  μm, Table  2  [21]). A  larger mean diameter  in  hCOL 
contributes  to  a  larger  network  volume  ((10.4  ±  0.8)  ×  105  μm3,  Table  2  [21],)  compared  to 
hCOL/Agarose  construct  ((6.9  0.9) × 105  μm3, Table 1). Additionally, other network parameters 




4c)  compared  to  the MatrigelTM/rCOL/Agarose  construct  (Figure 4d). This was  further  confirmed 
through network quantification with a mean diameter of 7.7  2.6 μm (Table 1) for network containing 
MatrigelTM/rCOL/Agarose  compared  to  9.3 ± 2.4  μm  for MatrigelTM/rCOL  as  shown  in  a different 
study  by  our  group  [21].  Except  number  of  segments,  other  network  parameters  showed  no 
Figure 4. A 3D reconstruction of EC networks revealing the effect of agarose supplementation
on the network structure and thickness. 3D reconstruction of multiphoton images obtained from
constructs containing GFP-HUVECs and hASCs in hCOL (a,e), hCOL/Agarose (b,f), MatrigelTM/rCOL
(c,g) or MatrigelTM/rCOL/Agarose (d, ) cultivated for 14 days. (a–d) 3D reconstruction of EC
network employing the calculated m an diameter for each hydrogel setting. (e–h) Side view of
the 3D reconstruction demonstrating the height of the EC network. Networks generated in agarose
supplemented hCOL hydrogel are multi-layered with larger height and exhibit a smaller mean diameter
compared to constructs generated with hCOL which have a mono-layer structure with thinner height.
Networks generated in constructs generated with MatrigelTM/rCOL/Agarose are multi-layered with
same height and exhibit a slightly smaller mean diameter compared to n tworks i control hydrogel
containing MatrigelTM/rCOL hydrogel. Scale bars: 100 µm.
A comparison of the reconstructed EC networks in the different hydrogel compositions showed a
more filigree network with smaller mean diameter in construct containing hCOL/agarose (Figure 4b)
compared to network formed in agarose-free hCOL construct (Figure 4a). Additionally, the network in
hCOL seemed to resemble a monolayer and has a smaller height (Figur 4e) compared to a ulti-layered
network in hCOL-Agarose construct (Figure 4f). These differences are confirmed by quantification of
network parameters in constructs containing hCOL/Agarose. The latter has a smaller network mean
diameter (7.7 ± 2.6 µm, Table 1) compared to agarose-free hCOL as shown in a previous study by our
group (12.2 ± 3.3 µm, Table 2 [21]). A larger mean diameter in hCOL contributes to a larger network
volume ((10.4± 0.8)× 105 µm3, Table 2 [21],) compared to hCOL/Agarose construct ((6.9± 0.9)× 105 µm3,
Table 1). Additionally, othe network parameters (number f nodes, total branchin length, and number
of segments) are larger in hCOL/Agarose constructs compare to agarose-free hCOL, which explains
the more filigree structure of the network in hCOL/Agarose (Figure 4a,b, Table 1, Table 2 [21]).
As for the MatrigelTM/rCOL setting, a slightly larger network diameter was observed in the control
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construct containing MatrigelTM/rCOL (Figure 4c) compared to the MatrigelTM/rCOL/Agarose construct
(Figure 4d). This was further confirmed through network quantification with a mean diameter of
7.7 ± 2.6 µm (Table 1) for network containing MatrigelTM/rCOL/Agarose compared to 9.3 ± 2.4 µm
for MatrigelTM/rCOL as shown in a different study by our group [21]. Except number of segments,
other network parameters showed no significant differences (Table 1, Table 2 [21]) explaining the similar
network structure in both agarose-containing and agarose-free MatrigelTM/rCOL constructs. The aim
of generating such constructs with stable EC network is to provide a platform for clinically applicable
prevascularized scaffolds with capillary-like functionality. The EC networks formed in agarose-collagen
composite hydrogel have an average diameter range (7.2–7.7µm) close to the size of large capillaries [37]
and therefore have the geometrical potential to supply cells within an engineered tissue if connected to
a perfusion system.
Table 1. Comparison of network parameters in agarose supplemented constructs. Constructs containing
GFP-HUVECs and hASCs in hCOL/Agarose and MatrigelTM/rCOL/Agarose were cultured for 14 days.
After cultivation period, z-stacks of constructs were taken at three random regions per construct using
multiphoton microscopy. The stacks were processed with Imaris for 3D reconstruction and network
quantification. Network parameters are presented as mean ± SD for: mean diameter, number of nodes,
total branching length, network area, network volume, and number of segments. Data were analyzed
with unpaired t-test. (*) p-value ≤ 0.05, ns: not significant.
MatrigelTM/rCOL/Agarose hCOL/Agarose Significance
Mean Diameter (µm) 7.2 ± 2.2 7.7 ± 2.6 ns
Number of nodes 137.6 ± 20.2 102.0 ± 11.2 ns
Total branching length (µm) 15,300.0 ± 1248.9 13,366.6 ± 1222.0 ns
Network area (µm2) (3.4 ± 0.45) × 105 (3.2 ± 0.2) × 105 ns
Network Volume (µm3) (6.7 ± 1.2) × 105 (6.9 ± 0.9) × 105 ns
Number of segments 250.3 ± 34.2 182.3 ± 17.0 *
Table 2. Constructs containing GFP-HUVECs and hASCs in MatrigelTM/rCOL and hCOL were cultured
for 14 days. After cultivation period, z-stacks of constructs were taken at three random regions per
construct using multiphoton microscopy. The stacks were processed with Imaris for 3D reconstruction
and network quantification. Network parameters are presented as mean ± SD for: mean diameter,
number of nodes, total branching length, network area, network volume, and number of segments.
Data were analyzed with unpaired t-test. (*) p-value ≤ 0.05, ns: not significant. Data re-used from
Andrée et. al. [21].
MatrigelTM/rCOL hCOL Significance
Mean Diameter (µm) 9.3 ± 2.4 12.2 ± 3.3 ns
Number of nodes 113.0 ± 19.3 81.7 ± 4.0 ns
Total branching length (µm) 10,747.0 ± 938.9 8357.3 ± 526.6 *
Network area (µm2) (3.2 ± 0.3) × 105 (3.2 ± 0.1) × 105 ns
Network Volume (µm3) (7.7 ± 1.0) × 105 (10.4 ± 0.8) × 105 *
Number of segments 207.3 ± 34.6 146.3 ± 4.2 *
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The difference in network height observed in hCOL-based constructs can be attributed to either
cell loss taking place in hydrogel constructs containing hCOL or cell division (not addressed in
this study) occurring in hydrogel constructs containing hCOL/agarose. In the context of angiogenesis,
it has been reported that the VEGF-mediated endothelial cell proliferation can be associated with
increased matrix stiffness [38]. Therefore, future investigation should address the effect of agarose
supplementation on the mechanical properties of collagen-agarose composite hydrogels and on cell
fate over cultivation time.
2.5. hASCs/HUVECs Interaction in Agarose-Containing Constructs
To assess the interaction of hASCs and HUVECs in agarose-containing constructs, staining
against alpha-smooth muscle actin of whole constructs was performed at the end of the cultivation
period of 14 days. Confocal microscopy analysis of the respective controls (Figure 5a,e for hCOL,
Figure 5c,f for MatrigelTM/rCOL) and the agarose supplemented constructs showed α-SMA positive
cells surrounding the cords of GFP-labelled HUVECs in both constructs, hCOL/agarose (Figure 5b,g)
and MatrigelTM/rCOL/agarose (Figure 5d,h), which indicates that agarose does not prevent direct
contact of hASCs with HUVECs, but instead acts as a scaffold by providing the physical space for
HUVECs and hASCs to interact and finally develop mature vascular-like networks. Similar findings
are reported in studies using collagen either alone or with fibrin as composite hydrogels. For the latter,
Peterson et al. showed that collagen-fibrin matrix efficiently entrapped human ECs and fibroblasts in
a 3D co-culture setting by supporting their viability and spreading [39]. ECs formed networks that
were visible at day 7 of culture and more prominent by day 14 of culture with fibroblasts co-localizing
with ECs. Additionally, in our study, orthogonal views of the confocal images show no obvious cord
diameter differences between constructs containing MatrigelTM/rCOL (Figure 5f) and those containing
MatrigelTM/rCOL/Agarose (Figure 5h). In contrary, larger cords are observed in hCOL hydrogel
constructs (Figure 5e) compared to hCOL/Agarose constructs (Figure 5g). The reason for this difference
is unclear, but it can be hypothesized that an increase of hydrogel stiffness, by addition of agarose,
can lead to decreased cord diameter in EC networks. A similar pattern was reported in a study by
Whisler et al., where fibrin was used at different concentration for the co-culture of HUVECs and human
lung fibroblasts [40]. A higher concentration of fibrin resulted in a decreased cord diameter in the EC
network. It is noteworthy that a strong increase in hydrogel stiffness may alter the formation of EC
networks as reported elsewhere [29]. Therefore, an optimal value of hydrogel stiffness for the respective
set-up needs to be determined. In addition, confocal images underlined the distribution of the EC
network in agarose supplemented constructs throughout a larger height (Figure 5g,h) than constructs
without agarose (Figure 5e,f). Furthermore, the multi-layered structure of the network is apparent in
agarose supplemented hydrogels (Figure 5g,h). Therefore, the EC network in the overview pictures
(Figure 5b,d) looks less dense compared to the respective controls (Figure 5a,c), as just one focal plane
is depicted.
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3. Conclusions
In this study addition of SeaPlaqueTM agarose to our standard MatrigelTM/rCOL hydrogel has
noticeably contributed to an increase of the hydrogel thickness while preserving the formation of
HUVEC vascular-like networks. In the case of hCOL, the agarose supplementation did not reveal
differences in terms of construct thickness. Importantly, however, agarose has led to the formation of a
multi-layered EC network compared to control constructs containing hCOL only while a multi-layered
EC network was achieved in MatrigelTM/rCOL-based hydrogel with or without agarose. Further work
should focus on assessing the effect of agarose on the biomechanical properties of the agarose-collagen
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composite hydrogels. Several agarose-based products have been FDA approved and are in use clinically
as dermal fillers without adverse effects [41–43]. Additionally, owing to the agarose’s reversible
thermos-gelling behavior and non-cytotoxic effects, agarose-based hydrogels can be exploited to
develop a wide range of biomaterials for tissue engineering applications.
Finally, a main challenge of pre-vascularized scaffolds is the establishment of a connection to
perfusion system in vitro and to a suitable system in the host circulatory system in vivo.
4. Materials and Methods
4.1. Ethics Statement
Patient material was processed following approval of the Ethics Committee at Hannover Medical
School (file reference 3475-2017) and after obtaining written informed consent from the patients.
All tissues were used anonymously for this study. All experiments were performed in accordance with
relevant guidelines and regulations.
4.2. Preparation of Small Intestinal Submucosa (SIS)
The preparation of decellularized small intestinal submucosa (SIS) was performed as previously
described [44]. In brief, porcine small intestinal segments were isolated from German landrace
pigs (18–25 kg) and stored in undiluted Braunol (7.5% povidone-iodine solution in water, B. Braun,
Melsungen, Germany) at 4 ◦C. Tunica mucosa and tunica serosa of intestinal segments were mechanically
removed, followed by a chemical decellularization in 1% Triton X-100 in 10 mM TRIS, pH 7.5 under
continuous shaking (90 rpm) at room temperature for 24 h. Afterwards, SIS was washed with distilled
water for 24 h under continuous shaking, followed by washing with phosphate buffered saline
(PBS) supplemented with 1 g/L Vancomycin, 100 mg/L Gentamicin, and 2.5 mg/L Amphotericin B
under continuous shaking for 10 days at room temperature with daily change of washing buffer.
Three different drugs were added to the washing solution to prevent the growth of gram-positive
bacteria (Vancomycin), gram-negative bacteria (Gentamicin), and fungi (Amphotericin B). Finally,
SIS in a small amount of PBS was sterilized by 150 Gy gamma-ray irradiation (Gamma cell, Mölsgaard
Medical Denmark, Kopenhagen, Denmark) and stored in PBS at 4 ◦C until further use for a maximum
of 6 months. Before use, SIS was cut open along the longitudinal axis, fixed in a metal frame with
the submucosal side facing up and covered with culture medium.
4.3. Human Umbilical Vein Endothelial Cells (HUVECs)
HUVECs obtained from pooled donors were purchased from Lonza. Cells were cultured in
Endothelial Growth Medium 2 (EGM-2, Lonza, Basel, Switzerland). Passages 5–7 were used for
all experiments.
4.4. Isolation of Adult Human Adipose Tissue-Derived Stromal Cells (hASCs)
Human adult adipose tissue-derived stromal cells (hASCs) were isolated from human tissues
that were obtained from patients undergoing abdominoplasty. Isolation was performed according
to a previously published protocol with minor modifications [45]. In brief, fat and connective
tissue were minced, followed by addition of 10 mL Collagenase type II solution (760 U/mL,
Worthington, Lakewood, NJ, USA) per 20 mL of tissue and incubation for 1 h at 37 ◦C under
shaking. Fatty supernatants were collected and washed with PBS. After centrifugation, the cell pellet
was washed with PBS, resuspended and cells were cultivated in EGM-2. The medium was changed
after 48 h followed by a medium change every other day. Cells from passages 2–4 were used for
the experiment.
Gels 2020, 6, 27 12 of 16
4.5. Preparation of Lentiviral Supernatants and Cell Transduction
Lentiviral transductions of HUVECs were carried out under biosafety level 2 (S2) regulations.
For the transduction, HUVECs in an early passage (P1 or P2) were seeded into T75 cell culture flasks
in EGM-2. The medium containing the virus was replaced after 48 h. Efficiency of transduction was
monitored microscopically by estimating the proportion of GFP positive cells or by FACS analysis [46].
4.6. Preparation of 0.4% SeaPlaqueTM Agarose
For the preparation of 100 mL of 0.4% SeaPlaqueTM agarose (Lonza, Basel, Switzerland), 0.8 g of
SeaPlaqueTM agarose powder was added to an Erlenmeyer glass flask containing 100 mL of Ampuwa
water. The mixture was boiled until the agarose was completely dissolved. The solution was further
diluted 1:1 in serum-free medium [21] to prepare a 0.4% agarose solution.
4.7. Generation of 3D Hydrogel Constructs in Serum-Free Culture
For the generation of 3D hydrogel constructs containing GFP-HUVECs and hASCs in rCOL
and MatrigelTM cultured in serum-free medium, slight modification of previously published protocol
from our group was used [20] (Tables S1–S5). Briefly, rCOL (Trevigen Inc., Gaithersburg, MD, USA)
or hCOL (Sigma-Aldrich, Taufkirchen, Germany), double distilled water (ddH2O), gel medium,
and 0.4 mM NaOH were mixed. For constructs containing MatrigelTM, 31 µL of MatrigelTM (BD
Biosciences, Billerica, MA, USA) was added. A mixture of 1.7 × 106 GFP-HUVECs and 3 × 106 hASCs
was resuspended in serum-free medium and mixed with the hydrogel. For constructs supplemented
with 0.4% SeaPlaqueTM agarose, 57 µL is added to the hydrogel mixture which was cast onto SIS-based
casting mold. After 1 hour of incubation in a humidified incubator at 37 ◦C and an atmosphere with
5% CO2, solidified hydrogel constructs were covered with serum-free medium. The medium change
was done every 2 days and the ECs network assembling was documented using a Stereo Discovery.V8
microscope equipped with an AxioCam camera and an HXP lamp (Carl Zeiss, Oberkochen, Germany.
4.8. Assessment of hASCs/HUVECs Interaction Using Immunofluorescence Staining
The staining procedure was performed according to a standard protocol and is described below.
At the end of the experiment, whole 3D constructs were fixed with 4% PFA at RT for 30 min followed by
3 washing steps, 5 min each, using PBS. Constructs were placed on glass slides. The construct specimens
were permeabilized with 0.3% Triton X-100 in PBS for 1 hour at room temperature and blocked with 2%
donkey serum in PBS for 40 min at RT followed by overnight incubation with anti-human α-smooth
muscle actin (α-SMA) (M0851, 1:400, DAKO, Santa Clara, CA, USA) at 4 ◦C. Specimens were washed
three times for 5 min each with PBS followed by incubation with Cy3-labelled donkey anti-mouse
antibody (1:300, Jackson ImmunoResearch, West Grove, PA, USA) for 2 h at RT. Specimens were
washed three times with PBS for 5 min each. Nuclei were counterstained with DAPI (1 µg/mL in
PBS) for 15 min at RT. After three additional washing steps with PBS for 5 min each, constructs were
covered with fluorescent mounting medium and glass coverslips. The specimens were left to dry for at
least 24 h at 4 ◦C. Specimens were analyzed using an Olympus FluoView 1000 confocal laser scanning
microscope (Olympus Europe, Hamburg, Germany).
4.9. Assessment of Constructs Thickness
At the end of the experiment, the whole 3D hydrogel constructs were fixed with 4% PFA at RT for
30 min to preserve the construct structure and the GFP signal for subsequent fluorescence microscopy.
After fixation, the constructs were washed three times with PBS and stored at 4 ◦C until further analysis.
For cryosection preparation constructs were transferred into optimal cutting temperature compound
(OCT) and left for 24 h at 4 ◦C. The OCT-embedded constructs were frozen in liquid nitrogen and stored
at −80 ◦C. The frozen constructs were mounted on a cryostat and 5 µm cryosections were prepared
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and transferred onto superfrost glass slides. The cryosections were dried at RT for 2 h before storage
at −80 ◦C.
Prior to nuclear staining using DAPI, the specimens were encircled with a PAP Pen and washed
three times with PBS for 5 min each to remove residuals of the water-soluble OCT. Nuclei were
stained with DAPI (1 µg/mL in PBS) for 15 min at RT. After three washing steps with PBS for 5 min
each, the stained cryosections were covered with fluorescent mounting medium and glass coverslips.
The specimens were left to dry for at least 24 h at 4 ◦C before they were analyzed using an Oberserver.
A1 microscope. An estimation of construct thickness was done by imaging of 3 different cryosections
for each hydrogel setting (one construct analyzed per setting). An imaging of the whole cryosection
was done (approximately nine images per cryosection) and five random thickness measurements were
taken per image. Hydrogel thickness is presented as mean ± SD.
4.10. 3D Reconstruction and Quantification of the EC Network
Image acquisition of the EC network formed by GFP-HUVECs was performed using a multiphoton
microscopy setup employing a Chameleon Ultra II laser system running at 790 nm or 850 nm (Coherent
Inc., Santa Clara, CA, USA), a Thorlabs MPM 200 multiphoton microscope body (Thorlabs, Newton,
NJ, USA), and an Olympus XLPlan N objective (25×, NA 1.05). Z-stacks were taken at three random
regions of each hydrogel setting (one construct analyzed per setting) with a z-step size of 1 µm.
The 3D reconstruction of the EC network was performed with Imaris software (Bitplane, Zürich,
Switzerland) using multiphoton z-stacks. The 3D quantification of EC network parameters was
performed employing an AutoPath algorithm of FilamentTracer in the Imaris software. Data are given
as mean ± SD for mean diameter, number of nodes, total branching length (sum of the lengths of
all segments within the 3D network), network area (the sum of areas of all segments within the 3D
network), network volume (the sum of volumes of all segments within the 3D network), and number
of segments. Data were analyzed with unpaired t-test. A p-value ≤0.05 was determined as significant.
Supplementary Materials: The following are available online at http://www.mdpi.com/2310-2861/6/3/27/s1,
Table S1: Control hydrogel construct containing MatrigelTM/rCOL in serum-free medium, Table S2: Control
hydrogel construct containing hCOL in serum-free medium, Table S3: Hydrogel construct containing MatrigelTM
and a high concentration of rCOL in serum-free medium, Table S4: Hydrogel construct containing MatrigelTM/rCOL,
and SeaPlaqueTM agarose in serum-free medium, Table S5: Hydrogel construct containing hCOL and SeaPlaqueTM
agarose in serum-free medium.
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